MOISHIA MCELROY: Open Payments
NPI 1659832368 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 25 payments from 14 companies in 2025. Trend: 2023 $725 · 2024 $989 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| ABBVIE INC. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Incyte Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $27 |
| Celgene Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
Products named: Fabhalta, ORGOVYX, OPDIVO, SCEMBLIX, EPKINLY, Nubeqa, OJJAARA, Stivarga.
Industry payments across TX — which companies pay providers there.
